RenovoRx, Inc. (RNXT)
RenovoRx Market Cap : 38.10M for May 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cytokinetics, Inc. | 10.05B |
| BioRestorative Therapies, Inc. | 5.200M |
| CytomX Therapeutics, Inc. | 849.04M |
| Tenaya Therapeutics, Inc. | 220.25M |
| Prime Medicine, Inc. | 595.13M |
Market Cap Related Metrics
| PS Ratio | 26.59 |
| Price to Book Value | 7.027 |
| Price | 0.8457 |
| Earnings Yield | -37.38% |